Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.

Lang J, Capasso A, Jordan KR, French JD, Kar A, Bagby SM, Barbee J, Yacob BW, Head LS, Tompkins KD, Freed BM, Somerset H, Clark TJ, Pitts TM, Messersmith WA, Eckhardt SG, Wierman ME, Leong S, Kiseljak-Vassiliades K.

J Clin Endocrinol Metab. 2019 Sep 12. pii: dgz014. doi: 10.1210/clinem/dgz014. [Epub ahead of print]

PMID:
31513709
2.

First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.

Capasso A, Bagby SM, Dailey KL, Currimjee N, Yacob BW, Ionkina A, Frank JG, Kim DJ, George C, Lee YB, Benaim E, Gittleman B, Hartman SJ, Tan AC, Kim J, Pitts TM, Eckhardt SG, Tentler JJ, Diamond JR.

Mol Cancer Ther. 2019 Sep 5. doi: 10.1158/1535-7163.MCT-18-1334. [Epub ahead of print]

PMID:
31488700
3.

Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.

Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y.

PLoS Negl Trop Dis. 2019 Aug 26;13(8):e0007622. doi: 10.1371/journal.pntd.0007622. eCollection 2019 Aug.

4.

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine.

Capasso A, Benigni A, Capitanio U, Danesh FR, Di Marzo V, Gesualdo L, Grandaliano G, Jaimes EA, Malyszko J, Perazella MA, Qian Q, Ronco P, Rosner MH, Trepiccione F, Viggiano D, Zoccali C, Capasso G; International Conference on Onco-Nephrology Participants.

Kidney Int. 2019 Sep;96(3):555-567. doi: 10.1016/j.kint.2019.04.043. Epub 2019 May 31.

PMID:
31445584
5.

Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.

Virostko J, Capasso A, Yankeelov TE, Goodgame B.

Cancer. 2019 Nov 1;125(21):3828-3835. doi: 10.1002/cncr.32347. Epub 2019 Jul 22.

PMID:
31328273
6.

Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines.

Cerchia C, Nasso R, Mori M, Villa S, Gelain A, Capasso A, Aliotta F, Simonetti M, Rullo R, Masullo M, De Vendittis E, Ruocco MR, Lavecchia A.

J Med Chem. 2019 Aug 8;62(15):7089-7110. doi: 10.1021/acs.jmedchem.9b00632. Epub 2019 Jul 24.

PMID:
31294975
7.

Acute colonic pseudo-obstruction in elderly Report of a case.

Formisano V, Cione G, Di Muria A, Di Carlo F, Capasso A, Russo S, Angrisani L.

Ann Ital Chir. 2019 May 5;8. pii: S2239253X19030548.

PMID:
31112520
8.

Identification of a Consolidation Phase in Immunological Memory.

Mantile F, Capasso A, De Berardinis P, Prisco A.

Front Immunol. 2019 Mar 19;10:508. doi: 10.3389/fimmu.2019.00508. eCollection 2019.

9.

Sexual Risk Behaviors Among Black and Puerto Rican Women in Their Late Thirties: A Brief Report.

Pahl K, Lee JY, Capasso A, Lekas HM, Brook JS, Winters J.

J Immigr Minor Health. 2019 Mar 28. doi: 10.1007/s10903-019-00877-7. [Epub ahead of print]

PMID:
30924047
10.

A quest for protecting kidneys from cisplatin toxicity.

Viggiano D, Capasso A, Capasso G.

Nephrol Dial Transplant. 2019 Oct 1;34(10):1623-1625. doi: 10.1093/ndt/gfz029. No abstract available.

PMID:
30815681
11.

Electrically Conducting and Mechanically Strong Graphene-Polylactic Acid Composites for 3D Printing.

Kim M, Jeong JH, Lee JY, Capasso A, Bonaccorso F, Kang SH, Lee YK, Lee GH.

ACS Appl Mater Interfaces. 2019 Mar 27;11(12):11841-11848. doi: 10.1021/acsami.9b03241. Epub 2019 Mar 12.

PMID:
30810305
12.

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.

Capasso A, Lang J, Pitts TM, Jordan KR, Lieu CH, Davis SL, Diamond JR, Kopetz S, Barbee J, Peterson J, Freed BM, Yacob BW, Bagby SM, Messersmith WA, Slansky JE, Pelanda R, Eckhardt SG.

J Immunother Cancer. 2019 Feb 8;7(1):37. doi: 10.1186/s40425-019-0518-z.

13.

Design and analysis of comparative experiments to assess the (dis-)comfort of aircraft seating.

Vanacore A, Lanzotti A, Percuoco C, Capasso A, Vitolo B.

Appl Ergon. 2019 Apr;76:155-163. doi: 10.1016/j.apergo.2018.12.012. Epub 2019 Jan 8.

PMID:
30642520
14.

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.

Pascarella G, Capasso A, Nardone A, Triassi M, Pignata S, Arenare L, Ascierto P, Curvietto M, Maiolino P, D'Aniello R, Montanino A, Laudato F, De Feo G, Botti G, Perrone F, Petrillo A, Cavalcanti E, Lastoria S, Maurea N, Morabito A.

PLoS One. 2019 Jan 8;14(1):e0210330. doi: 10.1371/journal.pone.0210330. eCollection 2019.

15.

[CRIMINAL RESPONSIBILITY OF MEDICAL AND ITS CASE LAW EVOLUTION. LEGAL AND ECONOMIC PROFILES].

Capasso A.

G Ital Nefrol. 2018 Dec;35(6). pii: 2018-vol6. Review. Italian.

PMID:
30550044
16.

Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?

Angelillo P, Capasso A, Ghia P, Scarfò L.

Eur J Intern Med. 2018 Dec;58:2-6. doi: 10.1016/j.ejim.2018.09.006. Epub 2018 Sep 26. Review.

PMID:
30268574
17.

BRAF fusions identified in melanomas have variable treatment responses and phenotypes.

Turner JA, Bemis JGT, Bagby SM, Capasso A, Yacob BW, Chimed TS, Van Gulick R, Lee H, Tobin R, Tentler JJ, Pitts T, McCarter M, Robinson WA, Couts KL.

Oncogene. 2019 Feb;38(8):1296-1308. doi: 10.1038/s41388-018-0514-7. Epub 2018 Sep 25.

PMID:
30254212
18.

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.

Diamond JR, Eckhardt SG, Pitts TM, van Bokhoven A, Aisner D, Gustafson DL, Capasso A, Sams S, Kabos P, Zolman K, Colvin T, Elias AD, Storniolo AM, Schneider BP, Gao D, Tentler JJ, Borges VF, Miller KD.

Breast Cancer Res. 2018 Aug 2;20(1):82. doi: 10.1186/s13058-018-1014-y.

19.

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models.

Capasso A, Pitts TM, Klauck PJ, Bagby SM, Westbrook L, Kaplan J, Soleimani M, Spreafico A, Tentler JJ, Diamond JR, Arcaroli JJ, Messersmith WA, Eckhardt SG, Leong S.

Anticancer Drugs. 2018 Oct;29(9):827-838. doi: 10.1097/CAD.0000000000000673.

20.

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer.

Krishnamurthy A, Dasari A, Noonan AM, Mehnert JM, Lockhart AC, Leong S, Capasso A, Stein MN, Sanoff HK, Lee JJ, Hansen A, Malhotra U, Rippke S, Gustafson DL, Pitts TM, Ellison K, Davis SL, Messersmith WA, Eckhardt SG, Lieu CH.

Cancer Res. 2018 Sep 15;78(18):5398-5407. doi: 10.1158/0008-5472.CAN-18-0316. Epub 2018 Jul 24.

21.

Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms.

Scott AJ, Arcaroli JJ, Bagby SM, Yahn R, Huber KM, Serkova NJ, Nguyen A, Kim J, Thorburn A, Vogel J, Quackenbush KS, Capasso A, Schreiber A, Blatchford P, Klauck PJ, Pitts TM, Eckhardt SG, Messersmith WA.

Mol Cancer Ther. 2018 Oct;17(10):2112-2122. doi: 10.1158/1535-7163.MCT-17-0131. Epub 2018 Jul 19.

22.

Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors.

Weekes CD, Rosen LS, Capasso A, Wong KM, Ye W, Anderson M, McCall B, Fredrickson J, Wakshull E, Eppler S, Shon-Nguyen Q, Desai R, Huseni M, Hegde PS, Pourmohamad T, Rhee I, Bessudo A.

Cancer Chemother Pharmacol. 2018 Aug;82(2):339-351. doi: 10.1007/s00280-018-3622-8. Epub 2018 Jun 15.

PMID:
29905898
23.

Medical Complications in Anorexia and Bulimia Nervosa.

Gravina G, Milano W, Nebbiai G, Piccione C, Capasso A.

Endocr Metab Immune Disord Drug Targets. 2018;18(5):477-488. doi: 10.2174/1871530318666180531094508. Review.

PMID:
29848283
24.

Short Exposures to an Extremely Low-Frequency Magnetic Field (ELF MF) Enhance Protein but not mRNA Alkaline Phosphatase Expression in Human Osteosarcoma Cells.

Rescigno T, Capasso A, Bisceglia B, Tecce MF.

Open Biochem J. 2018 Apr 17;12:65-77. doi: 10.2174/1874091X01812010065. eCollection 2018.

25.

Protective and Restorative Effects of Nutrients and Phytochemicals.

Rescigno T, Tecce MF, Capasso A.

Open Biochem J. 2018 Apr 17;12:46-64. doi: 10.2174/1874091X01812010046. eCollection 2018. Review.

26.

The intracavitary electrocardiography method for tip location of jugular internal vein access device in infants of less than 5 kg: A pilot study.

Mastroianni R, Capasso A, Ausanio G.

J Vasc Access. 2018 Nov;19(6):639-643. doi: 10.1177/1129729818769028. Epub 2018 Apr 13.

PMID:
29651905
27.

The intracavitary electrocardiography method for positioning the tip of epicutaneous cava catheter in neonates: Pilot study.

Capasso A, Mastroianni R, Passariello A, Palma M, Messina F, Ansalone A, Bernardo I, Brescia D, Crispino F, Grassia C, Romano A, Ausanio G.

J Vasc Access. 2018 Nov;19(6):542-547. doi: 10.1177/1129729818761292. Epub 2018 Mar 18.

PMID:
29552936
28.

Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders.

Capasso A, Milano W, Cauli O.

Endocr Metab Immune Disord Drug Targets. 2018;18(4):325-332. doi: 10.2174/1871530318666180213112406. Review.

PMID:
29437028
29.

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.

Klauck PJ, Bagby SM, Capasso A, Bradshaw-Pierce EL, Selby HM, Spreafico A, Tentler JJ, Tan AC, Kim J, Arcaroli JJ, Purkey A, Messersmith WA, Kuida K, Eckhardt SG, Pitts TM.

BMC Cancer. 2018 Feb 5;18(1):136. doi: 10.1186/s12885-018-4036-z.

30.

Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview.

Capasso A.

Open Neurol J. 2017 Dec 18;11:61-73. doi: 10.2174/1874205X01711010061. eCollection 2017. Review.

31.

Neuroendocrine and Metabolic Disorders in Bulimia Nervosa.

Milano W, Capasso A.

Endocr Metab Immune Disord Drug Targets. 2018;18(4):297-305. doi: 10.2174/1871530318666171212092725. Review.

PMID:
29231147
32.

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.

Martinelli E, Sforza V, Cardone C, Capasso A, Nappi A, Martini G, Napolitano S, Rachiglio AM, Normanno N, Cappabianca S, Reginelli A, Bisceglie MD, Latiano TP, Maiello E, Orditura M, De Vita F, Morgillo F, Ciardiello F, Troiani T.

ESMO Open. 2017 Jul 29;2(3):e000177. doi: 10.1136/esmoopen-2017-000177. eCollection 2017.

33.

An ab initio study of hydroxylated graphane.

Buonocore F, Capasso A, Lisi N.

J Chem Phys. 2017 Sep 14;147(10):104705. doi: 10.1063/1.4986858.

PMID:
28915759
34.

Involvement of nutrients and nutritional mediators in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression.

Rescigno T, Capasso A, Tecce MF.

J Cell Physiol. 2018 Apr;233(4):3306-3314. doi: 10.1002/jcp.26177. Epub 2017 Sep 28.

PMID:
28888048
35.

Contamination-free graphene by chemical vapor deposition in quartz furnaces.

Lisi N, Dikonimos T, Buonocore F, Pittori M, Mazzaro R, Rizzoli R, Marras S, Capasso A.

Sci Rep. 2017 Aug 30;7(1):9927. doi: 10.1038/s41598-017-09811-z.

36.

Primary fibrosarcoma of the urinary bladder in a cat: follow-up after incomplete surgical excision.

Greci V, Rocchi PM, Sontuoso AF, Olivero D, Capasso A, Raiano V.

JFMS Open Rep. 2017 Jun 19;3(1):2055116917714881. doi: 10.1177/2055116917714881. eCollection 2017 Jan-Jun.

37.

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer.

Ionkina AA, Tentler JJ, Kim J, Capasso A, Pitts TM, Ryall KA, Howison RR, Kabos P, Sartorius CA, Tan AC, Eckhardt SG, Diamond JR.

Front Oncol. 2017 May 15;7:94. doi: 10.3389/fonc.2017.00094. eCollection 2017.

38.

Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach.

Milano W, Colletti C, Capasso A.

Endocr Metab Immune Disord Drug Targets. 2017;17(1):38-55. doi: 10.2174/1871530317666170424102332. Review.

PMID:
28440197
39.

Bioactive Nutrients and Nutrigenomics in Age-Related Diseases.

Rescigno T, Micolucci L, Tecce MF, Capasso A.

Molecules. 2017 Jan 8;22(1). pii: E105. doi: 10.3390/molecules22010105. Review.

40.

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies.

Bagby S, Messersmith WA, Pitts TM, Capasso A, Varella-Garcia M, Klauck PJ, Kim J, Tan AC, Eckhardt SG, Tentler JJ, Arcaroli J.

J Vis Exp. 2016 Sep 30;(115). doi: 10.3791/54393.

41.

Chemical Vapor Deposited Graphene-Based Derivative As High-Performance Hole Transport Material for Organic Photovoltaics.

Capasso A, Salamandra L, Faggio G, Dikonimos T, Buonocore F, Morandi V, Ortolani L, Lisi N.

ACS Appl Mater Interfaces. 2016 Sep 14;8(36):23844-53. doi: 10.1021/acsami.6b06749. Epub 2016 Aug 30.

PMID:
27575588
42.

Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer.

Pitts TM, Bradshaw-Pierce EL, Bagby SM, Hyatt SL, Selby HM, Spreafico A, Tentler JJ, McPhillips K, Klauck PJ, Capasso A, Diamond JR, Davis SL, Tan AC, Arcaroli JJ, Purkey A, Messersmith WA, Ecsedy JA, Eckhardt SG.

Oncotarget. 2016 Aug 2;7(31):50290-50301. doi: 10.18632/oncotarget.10366.

43.

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance.

Quackenbush KS, Bagby S, Tai WM, Messersmith WA, Schreiber A, Greene J, Kim J, Wang G, Purkey A, Pitts TM, Nguyen A, Gao D, Blatchford P, Capasso A, Schuller AG, Eckhardt SG, Arcaroli JJ.

Oncotarget. 2016 May 10;7(19):28273-85. doi: 10.18632/oncotarget.8626.

44.

Cannabinoids for the Treatment of Schizophrenia: An Overview.

Capasso A, Sobarzo-Sánchez E, Nabavi SF, Rastrelli L.

Curr Top Med Chem. 2016;16(17):1916-23. Review.

PMID:
26845552
45.

Nitrogen-doped graphene films from chemical vapor deposition of pyridine: influence of process parameters on the electrical and optical properties.

Capasso A, Dikonimos T, Sarto F, Tamburrano A, De Bellis G, Sarto MS, Faggio G, Malara A, Messina G, Lisi N.

Beilstein J Nanotechnol. 2015 Oct 14;6:2028-38. doi: 10.3762/bjnano.6.206. eCollection 2015.

46.

The changing landscape of phase I trials in oncology.

Wong KM, Capasso A, Eckhardt SG.

Nat Rev Clin Oncol. 2016 Feb;13(2):106-17. doi: 10.1038/nrclinonc.2015.194. Epub 2015 Nov 10. Review.

PMID:
26552953
47.

Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.

Rescigno T, Capasso A, Tecce MF.

J Cell Physiol. 2016 Jun;231(6):1226-36. doi: 10.1002/jcp.25217. Epub 2015 Oct 26.

PMID:
26480024
48.

Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.

Capasso A, Cerchia C, Di Giovanni C, Granato G, Albano F, Romano S, De Vendittis E, Ruocco MR, Lavecchia A.

Oncotarget. 2015 Nov 24;6(37):40202-22. doi: 10.18632/oncotarget.5473.

49.

Fibrosarcoma of the urinary bladder in a cat.

Capasso A, Raiano V, Sontuoso A, Olivero D, Greci V.

JFMS Open Rep. 2015 Jun 12;1(1):2055116915585019. doi: 10.1177/2055116915585019. eCollection 2015 Jan-Jun.

50.

The changing landscape of phase I trials in oncology.

Wong KM, Capasso A, Eckhardt SG.

Am Soc Clin Oncol Educ Book. 2015:3-8. doi: 10.14694/EdBook_AM.2015.35.3. Review. No abstract available.

Supplemental Content

Loading ...
Support Center